MY134740A - Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter - Google Patents

Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter

Info

Publication number
MY134740A
MY134740A MYPI20050714A MY134740A MY 134740 A MY134740 A MY 134740A MY PI20050714 A MYPI20050714 A MY PI20050714A MY 134740 A MY134740 A MY 134740A
Authority
MY
Malaysia
Prior art keywords
helicobacter
selection
lactic acid
acid bacteria
reducing inflammation
Prior art date
Application number
Inventor
Bo M Xd Llstam
Eamonn Connolly
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Priority to MYPI20050714 priority Critical patent/MY134740A/en
Publication of MY134740A publication Critical patent/MY134740A/en

Links

Abstract

STRAINS OF LACTOBACILLUS WHICH HAVE BEEN SELECTED FOR THEIR CAPABILITY OF REDUCING GASTROINTESTINAL INFLAMMATION, SUCH AS THAT DUE TO HELICOBACTER PYLORI, AND PRODUCTS DERIVED FROM THESE STRAINS, INCLUDING AGENTS FOR TREATMENT OR PROPHYLAXIS OF INFLAMMATION ASSOCIATED WITH HELICOBACTER PYLORI FOR ADMINISTRATION TO HUMANS AND INCLUDE CONDITIONED MEDIA IN WHICH THE SELECTED STRAINS HAVE GROWN AND PROTEIN CONTAINING EXTRACTS OF THE CONDITIONED MEDIA.
MYPI20050714 2005-02-24 2005-02-24 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter MY134740A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20050714 MY134740A (en) 2005-02-24 2005-02-24 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20050714 MY134740A (en) 2005-02-24 2005-02-24 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter

Publications (1)

Publication Number Publication Date
MY134740A true MY134740A (en) 2007-12-31

Family

ID=47291705

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20050714 MY134740A (en) 2005-02-24 2005-02-24 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter

Country Status (1)

Country Link
MY (1) MY134740A (en)

Similar Documents

Publication Publication Date Title
MX2018009539A (en) Use of microbial communities for human and animal health.
MX354047B (en) SPRAY-DRIED <i>LACTOBACILLUS</i> STEMS / CELLS AND THE USE OF SAME AGAINST <i>HELICOBACTER PYLORI.
BRPI1010637A2 (en) oral nutritional supplements comprising probiotics
WO2008053444A3 (en) Treating a respiratory condition with bifidobacterium
IN2012DN01638A (en)
MX338201B (en) Low post-acidifying lactic acid bacteria.
EP3584308A3 (en) Compositions and methods
ZA200803819B (en) Probiotic Enterococci for improved immunity
MX2009009318A (en) Probiotics to reduce episodes of diarrhoea in infants born by caesarean section.
GB2460781A (en) Probiotic bifidobacterium strains
UA109112C2 (en) Short-time high temperature treatment for preparing probiotic compositions intended for therapy of inflammatory disorders
MX2008006546A (en) Bifidobacteria that produces folic acid, food composition and use of said bifidobacteria.
WO2019066599A3 (en) Novel lactic acid bacteria and use thereof
UA94605C2 (en) Beta-galactosidase with transgalactosylating activity
WO2018165765A9 (en) Probiotic molecules for reducing pathogen virulence
PL2561880T3 (en) Lactic acid bacteria as probiotic strains and compositions containing same
WO2005112976A3 (en) Probiotic compounds from lactobacillus gg and uses therefor
WO2005060707A3 (en) Methods of use of probiotic lactobacilli for companion animals
BR0314511A (en) Selection and Use of Lactic Acid Bacteria to Reduce Helicobater Inflammation
UA88165C2 (en) Use of trisubstituted benzopyranones
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
UA94056C2 (en) Use of specific lactic acid bacteria for obtaining immunomodulatory compositions
WO2021004958A3 (en) Compositions comprising bacterial strains
WO2006101486A3 (en) Bacteriocins and novel bacterial strains
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus